Unlocking Evolutionary Biology

Transforming nature into medicines for patients with cancer and immune diseases.

Transcending the incremental

Over the course of millions of years, nature evolved to create the world’s most awe-inspiring, life-changing health outcomes. Peel Therapeutics identifies these evolutionary outliers to develop medicines for patients with cancer and inflammatory diseases.

About Us

We are an evolutionary-inspired, clinical-stage biotech company that translates nature’s superabilities into medicines to transform patients’ lives.

Our Science

Our technologies and expertise enable us to determine and deliver on the therapeutic potential of evolutionary outliers that circumvent disease.

Our Pipeline

Our clinical-stage therapeutic pipeline treats a spectrum of devastating conditions, with a near-term focus on cancer and inflammation.

The Latest from Peel

Catch-up with our latest announcements and events.

Peel Therapeutics to Present Data on its TOP1 Inhibitor PEEL-224 at the Connective Tissue Oncology Society Annual Meeting and Society for Immunotherapy of Cancer Annual Meeting